KNSA
Kiniksa Pharmaceuticals, Ltd.
NASDAQ · Healthcare · Biotechnology · BM
$77.91
−3.18%Forward multiples
Based on analyst estimates
- P/E forward
- 49.08x
- P/E 2026E
- 56.37x
- P/E 2027E
- 38.27x
- P/E 2028E
- 28.30x
- P/S forward
- 5.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 72.81x
- PEG TTM
- 1.52x
- Price / book
- 9.29x
- Price / sales
- 7.23x
- Price / cash flow
- 32.82x
Enterprise value
- Enterprise value
- $5.6B
- EV / sales
- 6.61x
- EV / EBITDA
- 49.62x
- EV / EBIT
- 55.48x
- Market cap
- $6.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026